Mark Cuban is a well-known name in the business world. As one of the “sharks” on the hit TV show Shark Tank, he has made a name for himself as an entrepreneur and an investor. In addition to his success in the tech and sports industries, Mark Cuban is also making waves in the healthcare industry with his latest venture: costplusdrugs.com.
In this episode, our host Andy Little is joined by EMRA*Cast Hosts Chris Reilly and Will Smith to sit down with Mark Cuban about the background and purpose of costplusdrugs.com, as well as its potential impact on the pharmaceutical industry. We will also take a look at Mark Cuban’s motivations for launching this project and what it means for consumers.
Cost Plus Drugs, Mark Cuban’s innovative venture, lowers the cost of prescription drugs for consumers primarily by sidestepping the traditional pharmaceutical supply chain. Where typical pharmacies incur multiple layers of costs from manufacturers, major pharmacy benefit managers (PBMs), and insurance companies, CostPlusDrugs substantially reduces these expenditures. It operates by procuring generic drugs directly from manufacturers and selling them to consumers at the production cost plus a flat rate for overhead. This transparent model eliminates the complex web of middlemen, markups, rebates, and hidden fees that often inflate drug prices. As a result, consumers gain affordable access to vital medications without the burden of inflated costs, which contributes to democratizing healthcare.
Additionally, Mark Cuban sheds light on their novel offering, TeamCubanCard.com. This benefit card allows patients to acquire their prescriptions from pharmacies at the same transparent prices found on CostPlusDrugs.com. It caters to those who favor the traditional method of physically picking up their prescriptions, rather than opting for mail-order delivery. The distinguishing factor of this benefits card, according to Cuban, is its unique operation outside of the conventional pharmaceutical system. This ensures that the card’s pricing remains consistent and does not fluctuate across different pharmacies.
Cost Plus Drugs carries over 1,400 medications, and the list is growing every day. All medications are from valid mainstream manufacturers and are FDA-approved.
In conclusion, CostPlusDrugs offers a transformative solution in the pharmaceutical industry. For patients, it provides an avenue for affordable access to vital medications, relieving the financial burden often associated with healthcare costs. It further extends its reach with the Team Cuban Card, offering consistent and transparent pricing across numerous pharmacies nationwide. For physicians, it reassures them that their patients can afford the medications they prescribe, thus ensuring adherence to treatment plans. As such, Mark Cuban’s foray into the healthcare sector with CostPlusDrugs signifies a significant step towards a more transparent, fair, and patient-centered pharmaceutical industry.
Post by Jordan Palmer, OMS-IV
About Our Guests:
Mark Cuban
American businessman, investor, film producer, and television personality
Chris Reilly, MD, MS
EMRA*Cast Host, Emergency Medicine physician
Will Smith, MD
EMRA*Cast Host, Emergency Medicine physician
Looking For More?
More from Andy, John, Tanner, and Drew: Be sure to subscribe to our newsletter for more information about what the team is reading, listening to and so much more!
More of your favorite EM Over Easy content: As always, you can find more of your favorite EM Over Easy content by following us on Twitter, Facebook, and Instagram! Also, please rate us on your favorite podcasting app or by visiting MedForums.
As the OFFICIAL podcast of the ACOEP, be sure to check out the ACOEP by visiting acoep.org to learn more and to sign up for one of their many CME offerings.